Newsletter | December 4, 2024

12.04.24 -- Developability Strategies That Improve Biologic Development

How A Robust Developability Approach Can De-Risk Biological Development

Developability bridges the gap between the ideal and the real by focusing on two fundamental questions: manufacturability and functionality. Utilizing a robust assessment platform enables us to whittle down candidates from hundreds to a handful. From there, we can keep refining the selection criteria, continually de-risking a project to reduce major cost, quality and time issues at later stages of manufacture and clinical evaluation.

 

Rapid Analytics: De-Risking Platform Strategies In Biopharmaceutical Drug Development

Leveraging Abzena's extensive expertise and fast data analysis, you can quickly uncover patterns and insights to guide both current and future projects. Our platform is built on a deep understanding of assay development, honed through the creation of hundreds of assays.

 

Accelerated Developability Assessments To Assist Lead Candidate Selection

This scientific poster focuses on rapid developability assessments as a key component in lead candidate selection for drug development, highlighting how Abzena’s Developability Assessment Platform streamlines the early identification and optimization of biologic drug candidates.

 

Formulating A Biologic: Frequently Asked Questions

Here, we take a look at some of the most frequently asked questions addressing the complexities and processes of drug formulation for biologics.  Gain insights into conducting a best-practice formulation strategy , which include physical and chemical assessments and optimization techniques to help ensure the best outcome in the clinic.

 

Leveraging Rapid & Accurate Analytical Data To Streamline Development

Access to rapid, analytical data allows you to make more informed decisions faster.  With its innovative approach to the assessment and validation of large molecules, LabZient™ is transforming the landscape of data analysis.  This standardized and automated platform enhances operational efficiencies and streamlines development timelines for biopharmaceuticals. Hear from one of Abzena’s Senior Analytical Leaders to learn more.

 

Optimal Formulation Development Strategies

Formulation plays a pivotal role in drug development. Gain insights into phase-appropriate de-risking strategies capable of guiding the selection and application of suitable formulation processes to achieve alignment with the optimal target product profile.

 

SOLUTIONS

Developability For Complex Biologics & Bioconjugates

Developability, a key factor in a biologic's success, evaluates its manufacturability, safety, and efficacy. By proactively addressing concerns, we aim to enhance the likelihood of regulatory approval.

• Request Information

 

 

 

Formulation Development: Navigating Concept-To-Market

By leveraging cutting-edge technological advancements, researchers can optimize formulations in terms of solubility, delivery method, safety profile, and sustained stability.

• Request Information

 

 

 

Streamlining Development With Rapid Analytical Data

LabZient™ by Abzena presents a breakthrough in analytical development for complex biologics, offering a cost-effective, efficient, and scientifically sound path to clinical trial readiness.

• Request Information